STRN-ALK Fusion in a Case of Malignant Peritoneal Mesothelioma: Mixed Response to Crizotinib, Mode of Resistance, and Brigatinib Sequential Therapy-Reference-Cited by-同舟云学术

STRN-ALK Fusion in a Case of Malignant Peritoneal Mesothelioma: Mixed Response to Crizotinib, Mode of Resistance, and Brigatinib Sequential Therapy

Published:2021-09 Issue:5 Volume: Page:1507-1513
ISSN:2473-4284
Container-title:JCO Precision Oncology
language:en
Short-container-title:JCO Precision Oncology

Author:

Gerthofer Valeria¹,Scheiter Alexander²^ORCID,Lüke Florian³⁴^ORCID,Keil Felix²^ORCID,Utpatel Kirsten²,Pöhmerer Laura-Maria-Giovanna²,Seitz Johannes⁵,Niessen Christoph⁵,Ignatov Atanas¹^ORCID,Dietmaier Wolfgang²,Calvisi Diego F.²,Evert Matthias²,Ortmann Olaf¹,Seitz Stephan¹

Affiliation:

1. Department of Gynecology and Obstetrics, University of Regensburg, Regensburg, Germany

2. Institute of Pathology, University of Regensburg, Regensburg, Germany

3. Department of Internal Medicine III, Hematology and Oncology, University Hospital Regensburg, Regensburg, Germany

4. Fraunhofer-Institut für Toxikologie und Experimentelle Medizin ITEM-R, Regensburg, Germany

5. Department of Radiology, Caritas-Krankenhaus St Josef, Regensburg, Germany

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

https://ascopubs.org/doi/pdfdirect/10.1200/PO.21.00184

Reference30 articles.

1. Fusion of a Kinase Gene, ALK , to a Nucleolar Protein Gene, NPM , in Non-Hodgkin's Lymphoma

2. A Case Report of Epithelioid Inflammatory Myofibroblastic Sarcoma with RANBP2-ALK Fusion Gene Treated with the ALK Inhibitor, Crizotinib

3. ALK as a paradigm of oncogenic promiscuity: different mechanisms of activation and different fusion partners drive tumors of different lineages

4. ALK fusion genes in children with atypical myeloproliferative leukemia

5. Two Cases of Renal Cell Carcinoma Harboring a Novel STRN-ALK Fusion Gene

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reticular Myxoid Odontogenic Neoplasm with Novel STRN::ALK Fusion: Report of 2 Cases in 3-Year-Old Males;Head and Neck Pathology;2024-03-25

2. Clinical Next Generation Sequencing Application in Mesothelioma: Finding a Golden Needle in the Haystack;Cancers;2023-12-06

3. Mesothelioma: Peritoneal, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology;Journal of the National Comprehensive Cancer Network;2023-09

4. Coexistence of a novel STRN-ALK, NBEA-ALK double-fusion in an ovarian malignant mesothelioma patient: a case report and review;Frontiers in Oncology;2023-04-21

5. Critical evaluation of molecular tumour board outcomes following 2 years of clinical practice in a Comprehensive Cancer Centre;British Journal of Cancer;2022-12-26